ABSORPTION, DISTRIBUTION, METABOLISM & EXCRETION STUDIES (ADME)

The staff at Clinical Pharmacology of Miami has experience with performing radiolabelled studies. At several other sites we have always had a State of Florida Radioactive Materials License which allowed us to administer 14Carbon and Tritium labeled compounds to more precisely characterize the absorption, distribution, metabolism and excretion of these compounds. We are in the process of applying for that license and anticipate having that capability soon. Please contact us for an updated status.

 

Metabolism and Excretion of the Dipeptidyl Peptidase 4 Inhibitor [14C] Sitagliptin in Humans
2007 Drug Metabolism and Disposition

DOWNLOAD
Absorption, Metabolism, and Excretion of Etoricoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Healthy male Volunteers
2003 Drug Metabolism and Disposition
DOWNLOAD


  
   POPULATIONS     > > > >


HEALTHY MALE & FEMALES 


HEPATICALLY IMPAIRED
 

RENALLY IMPAIRED
 

HYPERTENSIVE
 

GERIATRIC
 

DIABETIC
 

OBESE
 

  SPECIALTIES     > > > >

ADME 

FIRST IN HUMAN 

CARDIAC SAFETY 

  INFORMATION     > > > >

REPRINTS
 
   
   

 

©2008 CLINICAL PHARMACOLOGY OF MIAMI, Inc